Sonia Kamath, MD
Dermatology · Sunnyvale
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Kamath’s office at (650) 934-7676 to ask if they take your plan before you enroll.
California Medical Board record
Licence A138831 · Current
Licensed to practise in California · since 2015 · expires 2027-10-31 · University of Southern California Keck School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$1,922
Medicare paid this office $1,922 for 26 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Application of ultraviolet light to skin | 21 | $701 | $23 |
Who their Medicare patients are
26 Original Medicare patients in 2024. Average age 74 · Health risk score 0.78. At or below the middle of the specialty; the typical dermatology clinician is at 1.01.
Conditions among them: High blood pressure 62%.
The office billed $8,988, Medicare allowed $2,542 and paid $1,922; for 37 services of 5 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Medicaid work
$95,422 in 2022
Medicaid paid $95,422 for 750 billed services this clinician did in 2022, up to 48 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 167 | $71,847 |
| Return visit (30+ min) | 378 | $13,042 |
| New patient visit (45+ min) | 134 | $8,439 |
| Short return visit (20+ min) | 58 | $1,651 |
| Service | 13 | $443 |
| 2022 | 750 | 5 | 48 | $95,422 |
| 2021 | 1,478 | 8 | 80 | $209,402 |
| 2020 | 2,518 | 8 | 83 | $271,035 |
| 2019 | 623 | 5 | 56 | $55,939 |
See the largest Medicaid services in earlier years
2021
| Clinic visit/encounter, all-inclusive | 443 | $187,842 |
| Return visit (30+ min) | 597 | $13,923 |
| Short return visit (20+ min) | 216 | $3,515 |
| Service | 62 | $2,106 |
| New patient visit (45+ min) | 100 | $1,609 |
| Telehealth transmission, per minute, professional services bill separately | 12 | $254 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 25 | $153 |
| Negative screen for depressive symptoms as categorized by using a standardized depression screening/assessment tool (MDD) | 23 | $0 |
2020
| Clinic visit/encounter, all-inclusive | 557 | $232,832 |
| Short return visit (20+ min) | 936 | $17,248 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 369 | $8,444 |
| Return visit (30+ min) | 192 | $5,012 |
| Service | 143 | $4,791 |
| New patient visit (30+ min) | 54 | $1,168 |
| Telehealth transmission, per minute, professional services bill separately | 250 | $1,150 |
| Telehealth originating site facility fee | 17 | $390 |
2019
| Clinic visit/encounter, all-inclusive | 147 | $46,598 |
| Short return visit (20+ min) | 228 | $3,989 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 66 | $3,049 |
| Service | 48 | $1,637 |
| New patient visit (30+ min) | 134 | $667 |
Money from drug and device companies
$360 in 2025
| 2025 | 5 | 14 | None | $360 |
| 2024 | 4 | 6 | None | $297 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Arcutis Biotherapeutics | Zoryve | $157 | 9 payments
|
| Pfizer | Litfulo | $92 | 1 payment
|
| Genzyme | Dupixent | $47 | 1 payment
|
| Organon | Vtama | $43 | 2 payments
|
| Incyte | Opzelura | $22 | 1 payment
|
See all 14 published payments
| Arcutis Biotherapeutics | Meals · 2025-11-26 | Zoryve | $12 |
| Arcutis Biotherapeutics | Meals · 2025-11-20 | Zoryve | $31 |
| Arcutis Biotherapeutics | Meals · 2025-11-15 | Zoryve | $17 |
| Genzyme | Meals · 2025-10-20 | Dupixent | $47 |
| Arcutis Biotherapeutics | Meals · 2025-10-16 | Zoryve | $16 |
| Incyte | Meals · 2025-10-08 | Opzelura | $22 |
| Arcutis Biotherapeutics | Meals · 2025-09-30 | Zoryve | $5 |
| Arcutis Biotherapeutics | Meals · 2025-08-27 | Zoryve | $19 |
| Pfizer | Meals · 2025-07-25 | Litfulo | $92 |
| Organon | Meals · 2025-07-22 | Vtama | $26 |
| Arcutis Biotherapeutics | Meals · 2025-07-22 | Zoryve | $16 |
| Organon | Meals · 2025-03-21 | Vtama | $17 |
| Arcutis Biotherapeutics | Meals · 2025-02-18 | Zoryve | $14 |
| Arcutis Biotherapeutics | Meals · 2025-01-24 | Zoryve | $27 |
See earlier years (2024)
2024: $297
| Genzyme | Dupixent | $129 | 3 payments
|
| Regeneron Healthcare Solutions | None | $125 | 1 payment
|
| Ucb | Bimzelx | $24 | 1 payment
|
| Verrica Pharmaceuticals | Ycanth | $19 | 1 payment
|
Professional record
- NPI
- 1821480757
- Licence
- CA A138831California A138831: Current · expires 2027-10-31
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207N00000X (207N00000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2015-03-02
- NPI last updated
- 2023-07-21
- NPI record certified
- 2023-07-21
This is when the NPI record was last certified, not a medical board exam.